Keytruda is arguably the best oncology treatments on the market, so for NT-219 to convert non-responder to a responder is a remarkable talent. It is one thing for NT-219 to increase the effectiveness of a drug, but to unlock the tumor to a drug is a novel idea. $ktov $mrk